Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)
VRCA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
81.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
23.50%
VRCA Stock Analysis
VRCA
PE Ratio:
VRCA
PEG Ratio:
Not Available
VRCA
Forward EPS Growth (12 month):
0.00%
VRCA
PS Ratio:
1.7
VRCA
PSG Ratio:
VRCA
Forward Revenue Growth (12 month):
88.50%
VRCA Articles
No data was found